CYduct Diagnostics, Inc.
CYDX · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 45.5% | -13% | 74.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.5% | 65.8% | 68.9% | 70.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -340.2% | -603.9% | -394.2% | -935.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -394.2% | -681.4% | -461.8% | -1,041.6% |
| EPS Diluted | -0.018 | -0.022 | -0.017 | -0.022 |
| % Growth | 15.7% | -28.6% | 22.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |